BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

758909

544502

AMANTA

img img img img
No Data Available

Amanta Healthcare Ltd performance

Today’s low

Today’s high

₹ 99.46 ₹ 100.98
₹ 100.01

52 week low

52 week high

₹ 97.75 ₹ 154.40
₹ 100.01

Open Price

₹ 100.05

Prev. Close

₹ 99.07

Volume (Shares)

2191.00

Total traded value

₹ 2.19

Upper Circuit

₹ 118.88

Lower Circuit

₹ 79.26

info

Amanta Healthcare Ltd Share Price Update

As of the latest trading session, Amanta Healthcare Ltd share price is currently at ₹ 100.16, which is up by ₹ 1.09 from its previous closing. Today, the stock has fluctuated between ₹ 99.46 and ₹ 100.98. Over the past year, Amanta Healthcare Ltd has achieved a return of [-] %. In the last month alone, the return has been -16.13 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Amanta Healthcare Ltd fundamentals


  • Market cap (Cr)

    388.30

  • P/E Ratio (TTM)

    29.02

  • Beta

    1.00

  • Book Value / share

    54.25

  • Return on equity

    12.91%

  • EPS (TTM)

    3.60

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.21

info icon alternate text
  • Market cap (Cr)

    390.80

  • P/E Ratio (TTM)

    29.02

  • Beta

    0.78

  • Book Value / share

    54.25

  • Return on equity

    12.91%

  • EPS (TTM)

    3.60

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.21

info icon alternate text

Amanta Healthcare Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 70.89
Operating Expense 66.05
Net Profit 1.21
Net Profit Margin (%) 1.70
Earnings Per Share (EPS) 0.35
EBITDA 12.09
Effective Tax Rate (%) 46.92
Particulars JUN 2025 (Values in Cr)
Revenue 65.31
Operating Expense 61.33
Net Profit 3.51
Net Profit Margin (%) 5.37
Earnings Per Share (EPS) 1.22
EBITDA 15.86
Effective Tax Rate (%) 28.80
Particulars MAR 2025 (Values in Cr)
Revenue 72.06
Operating Expense 64.07
Net Profit 5.96
Net Profit Margin (%) 8.27
Earnings Per Share (EPS) 2.11
EBITDA 19.12
Effective Tax Rate (%) 26.87
Particulars DEC 2024 (Values in Cr)
Revenue 67.81
Operating Expense 0.00
Net Profit 2.65
Net Profit Margin (%) 3.90
Earnings Per Share (EPS) 0.92
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 66.73
Operating Expense 63.77
Net Profit 2.26
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 0.80
EBITDA 14.09
Effective Tax Rate (%) 28.70
Particulars MAR 2025 (Values in Cr)
Revenue 274.71
Operating Expense 261.39
Net Profit 10.50
Net Profit Margin (%) 3.82
Earnings Per Share (EPS) 3.71
EBITDA 61.05
Effective Tax Rate (%) 28.61
Particulars MAR 2024 (Values in Cr)
Revenue 280.34
Operating Expense 276.22
Net Profit 3.63
Net Profit Margin (%) 1.29
Earnings Per Share (EPS) 1.35
EBITDA 58.76
Effective Tax Rate (%) 32.65
Particulars MAR 2023 (Values in Cr)
Revenue 259.13
Operating Expense 260.01
Net Profit -2.11
Net Profit Margin (%) -0.81
Earnings Per Share (EPS) -0.79
EBITDA 56.31
Effective Tax Rate (%) 178.43
Particulars MAR 2025 (Values in Cr)
Book Value / Share 33.43
ROE % 12.91
ROCE % 14.77
Total Debt to Total Equity 2.12
EBITDA Margin 22.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.71
ROE % 5.62
ROCE % 13.88
Total Debt to Total Equity 2.68
EBITDA Margin 20.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 23.44
ROE % -3.37
ROCE % 13.13
Total Debt to Total Equity 2.88
EBITDA Margin 21.73
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.25
ROE % -36.56
ROCE % 12.05
Total Debt to Total Equity 5.66
EBITDA Margin 23.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.81
EBITDA Margin 23.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.47
Total Assets 381.75
Total Liabilities 381.75
Total Equity 96.38
Share Outstanding 28829351
Price to Book Ratio 0.00
Return on Assets (%) 2.75
Return on Capital (%) 3.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.10
Total Assets 352.11
Total Liabilities 352.11
Total Equity 66.28
Share Outstanding 26829351
Price to Book Ratio 0.00
Return on Assets (%) 1.03
Return on Capital (%) 1.34
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.86
Total Assets 374.06
Total Liabilities 374.06
Total Equity 62.88
Share Outstanding 26829351
Price to Book Ratio 0.00
Return on Assets (%) -0.56
Return on Capital (%) -0.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 9.53
Total Assets 391.96
Total Liabilities 391.96
Total Equity 72.37
Share Outstanding 26829351
Price to Book Ratio 0.00
Return on Assets (%) 14.05
Return on Capital (%) 19.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.87
Total Assets 392.11
Total Liabilities 392.11
Total Equity 7.26
Share Outstanding 26829351
Price to Book Ratio 0.00
Return on Assets (%) -5.56
Return on Capital (%) -10.74
Particulars MAR 2025 (Values in Cr)
Net Income 14.70
Cash from Operations 50.42
Cash from Investing -24.47
Cash from Financing -23.46
Net change in Cash -1.31
Free Cash Flow 71.19
Particulars MAR 2024 (Values in Cr)
Net Income 5.38
Cash from Operations 64.01
Cash from Investing -10.32
Cash from Financing -46.32
Net change in Cash 1.42
Free Cash Flow 77.43
Particulars MAR 2023 (Values in Cr)
Net Income 2.68
Cash from Operations 48.89
Cash from Investing -6.53
Cash from Financing -42.32
Net change in Cash -6.27
Free Cash Flow 55.18
Particulars MAR 2022 (Values in Cr)
Net Income 61.92
Cash from Operations 136.94
Cash from Investing -5.38
Cash from Financing -50.29
Net change in Cash 6.16
Free Cash Flow 146.91
Particulars MAR 2021 (Values in Cr)
Net Income -17.75
Cash from Operations 26.14
Cash from Investing -16.00
Cash from Financing -17.57
Net change in Cash -2.90
Free Cash Flow 39.63
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.39 12.94 1.37 202.24 25.97 / 68.00
BLISS GVS PHARMA LTD 160.80 15.51 1.50 1700.02 105.05 / 190.65
CIPLA LTD 1497.45 22.23 3.67 120959.70 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 264.70 6.95 1.99 779.04 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2543.40 45.20 25.23 43086.73 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.39 21.46 3.67 202.24 25.97 / 68.00
AMRUTAJAN HEALTH LTD 633.10 32.28 5.35 1830.33 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9021.60 97.56 28.22 22554.00 6301.00 / 10653.05
BLISS GVS PHARMA LTD 160.80 21.70 1.54 1700.02 105.05 / 190.65

Amanta Healthcare Ltd shareholding pattern

Holding

24.09%
63.55%
1.0%
11.33%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Amanta Healthcare Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
100.01 0.94 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 101.90
  • 26 Days 112.40
  • 10 Days 105.00
  • 50 Days 120.80
  • 12 Days 106.10
  • 100 Days 125.70
  • 20 Days 109.90
  • 200 Days 125.70
101.86 PIVOT

First Support

98.71

First Resistance

103.91

Second Support

96.66

Second Resistance

107.06

Third Support

93.51

Third Resistance

109.11

RSI

27.24

ADX

47.24

MACD

-6.07

Williams % R

-91.87

Commodity Channel Index (CCI)

-121.25

Date

2025-12-08

Week

62465.00

Same Day

128985.00

Month

75824.00

1 Year

0.97

3 Year

1.03

Over 1 Month

-16.13%

down

Over 1 Year

0.00%

down

Over 3 Months

-28.91%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Amanta Healthcare Ltd Corporate Actions

Amanta Healthcare Ltd Share Price

Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm 'Marck Parenterals (India)' on January 06, 1995. The Company's name was changed to 'Marck Biosciences Limited' on November 2, 2005 and further to 'Amanta Healthcare Limited' w.e.f. June 24, 2014. vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat.

Amanta Healthcare Limited is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, packed in plastic container with Aseptic Blow-Fill-Seal (ABFS) and Injection Strech Blow Moulding (ISBM) technology. The Company manufacture large volume parenterals (LVPs) and small volume parenterals (SVPs) in six therapeutic segments. In addition to that, it also manufacturer medical devices. It manufacture fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offer closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume ranging from 2ml to 1000 ml.

The Company introduced Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution in year 1997; and started the L-1 in Block A in 1998. It launched a specialised production line 'LVP Line II' for the manufacture of Large Volume Parenterals in Kheda District of Gujarat in 2002. Further, it launched a specialised production line 'SVP Line I' for the manufacture of Small Volume Parenterals in Kheda, Gujarat in 2005, launched L-III Large Volume Parenterals Facility for 500 ml products in Block -A in 2007; launched a specialised production line 'SVP line II' for the manufacture of Small Volume Parenterals in Gujarat in 2008.

Following the approval from National Company Law Tribunal, Ahmedabad, in October 2018, Marck Remedies Private Limited (MRPL) got merged with the Company through the Scheme of Amalgamation and the entire undertaking of MRPL was transferred to the Company as a going concern effective from April 1, 2017. In consideration of the transfer of MRPL's undertaking, 1 fully paid-up Equity Share of Rs 10 of the Company was issued and allotted for every 38 equity shares of Rs 10 each held in MRPL by their respective shareholders.

Later on, the Company launched a specialised production line 'SteriPort -Debottlenecking' in 2021 and is currently manufacturing out of seven (7) active production lines including SVP and LVP in 2024.

The Company launched the initial public offer by allotting 1,00,00,000 equity shares having the face value of Rs 10 each raising funds of Rs 12.6 Crore in September, 2025.

The Company has launched Linezolid I.V. Injection in FY 2025.

Parent organization Indian Private
NSE symbol AMANTA
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Amanta Healthcare Ltd?

Answer Field

Amanta Healthcare Ltd share price is for NSE ₹ 100.16 & for BSE ₹ 100.45 as on Dec 10 2025 09:59 AM.

What is the Market Cap of Amanta Healthcare Ltd Share?

Answer Field

The market cap of Amanta Healthcare Ltd for NSE ₹ 388.30 & for BSE ₹ 0.00 as on Dec 10 2025 09:59 AM.

What is the 52 Week High and Low of Amanta Healthcare Ltd?

Answer Field

The 52 Week High and Low of Amanta Healthcare Ltd for NSE is ₹ 154.40 and ₹ 97.75 and for BSE is ₹ 154.85 and ₹ 98.00.

What is 1 year return for Amanta Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Amanta Healthcare Ltd Share?

Answer Field

As on Dec 10 2025 09:59 AM the price-to-earnings (PE) ratio for Amanta Healthcare Ltd share is 29.02.

What is the PB ratio of Amanta Healthcare Ltd Share?

Answer Field

As on Dec 10 2025 09:59 AM, the price-to-book (PB) ratio for Amanta Healthcare Ltd share is 54.25.

How to Buy Amanta Healthcare Ltd Share?

Answer Field

You can trade in Amanta Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Amanta Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Amanta Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Amanta Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59